Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1452 results found. Search for [ Coronavirus vaccine US ]

Results 60 to 80 of 1452
BusinessToday.In
February 12, 2021
Sectorally, indices ended on a mixed note today. Gains in realty, IT, banking and financial stocks were capped by losses in pharma, FMCG, metal and auto scrips


BusinessToday.In
New Delhi, February 12, 2021
US President Joe Biden and his Chinese counterpart Xi Jinping held their first phone call as leaders and appeared at odds on most issues. While Xi has called for 'win-win' cooperation, Biden has called China America's 'most serious competitor' and vowed to 'out compete' Beijing; The job market continues to improve sequentially across the country, with job postings getting improved in some industries; The UK coronavirus variant that has wreaked havoc in the country and spread to multiple countries could eventually become the dominant strain, say experts. Watch this and more on News Blast.Also Read: Centre made Rs 100 crore by sharing vehicle data with private companies: Nitin Gadkari


Rashi Bisaria
New Delhi, February 12, 2021
Airlines allowed to operate 80% of pre-COVID-19 domestic flights till March 31 The cap on the number of domestic flights that Indian airlines are permitted to operate will remain at 80 per cent of their pre-COVID levels till March 31 or till the summer schedule begins, said the Civil Aviation Ministry on Thursday. The ministry had set the 80 per cent limit on December 3, 2020, without specifying till what date it would remain in place. Indian pharma grows for 5th straight month; sales ris...


BusinessToday.In
February 12, 2021
Stock Market News Updates Today: Earlier today, Sensex hit a record high of 51,804 and Nifty hit a lifetime high of 15,243


R S Subramanian
February 11, 2021
It is imperative that India can lean on and leverage its healthcare and logistics footprint and expertise to support the global fight against any pandemic


BusinessToday.In
February 11, 2021
RIL, Bajaj twins, Airtel, Hindalco, Adani Ports were among the top gainers while, Nestle, TCS, Axis Bank, L&T traded as the top losers


BusinessToday.In
February 11, 2021
India has achieved yet another milestone in its nationwide COVID-19 vaccination programme; Bihar and Tripura vaccinated highest number of registered healthcare workers


BusinessToday.In
February 11, 2021
Professor Sharon Peacock, head of UK's genetic surveillance progragramme, said that once the virus mutates itself out of being virulent then one can stop worrying about it


Rashi Bisaria
New Delhi, February 11, 2021
Twitter starts blocking censored accounts after govt's diktat After much hesitation in following the government's diktat on blocking accounts spreading fake \"farmers genocide\" hashtags, and those sympathising with Pakistan and Khalistan, Twitter has finally started blocking accounts that are spreading inflammatory and divisive comments, say government officials. Adar Poonawala firm Rising Sun to buy 60% stake in Magma Fincorp for Rs 3,456 crore Adar Poonawalla-led firm Rising Star Hol...


BusinessToday.In
February 11, 2021
Stock Market News Updates Today: RIL, Bajaj twins, Airtel were among the top gainers while, Nestle, TCS, Axis Bank, L&T traded as the top losers


BusinessToday.In
February 10, 2021
Indices erased opening gains and settled flat as profit booking was witnessed in FMCG, metal, banking and financial stocks


BusinessToday.In
February 10, 2021
Stock Market News Updates Today: Tata Motors, L&T , Infosys, Airtel, SBI, ONGC, ITC, Nestle were among the top losers today while HUL, Titan, M&M, TCS, Bajaj Finance, HDFC traded among the top gainers.


BusinessToday.In
February 9, 2021
Asian Paints, Axis Bank, ONGC, HDFC, Titan, L&T were the top gainers while SBI, Kotak Bank, Dr Reddy, NTPC, TCS were among the top losers


BusinessToday.In
New Delhi, February 9, 2021
Bitcoin breached the $44,000 mark for the first time on Monday after Tesla revealed that it had invested around $1.5 billion in the cryptocurrency last month; Drug firm AstraZeneca India on Monday said it has received marketing authorisation to use its anti-diabetic drug dapagliflozin for the treatment of patients with chronic kidney disease (CKD); Prime Minister Narendra Modi on Monday called newly elected US President Joe Biden and the two leaders discussed regional, environmental, and other issues. Watch this and more on News Blast.Also Read: COVID-19: AstraZeneca vaccine offers protection against severe disease, death, says WHO


PB Jayakumar
February 9, 2021
Godrej Appliances is currently deploying vaccine refrigerators that maintain a precise temperature of 2 to 8 degrees Celsius to store the highly temperature-sensitive Covaxin and CoviShield vaccines


PTI
February 9, 2021
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations


BusinessToday.In
February 9, 2021
Stock Market News Updates Today: Sensex hit a record high of 51,753 and the Nifty hit a record high of 51,753 in early trade today. Both benchmark indices have gained over 11% in seven straight sessions


BusinessToday.In
February 8, 2021
Stock Market Live News Today: Sensex and Nifty continued hitting new all-time highs today. Both benchmarks hit fresh lifetime highs of 51,523 and 15,159 earlier today


PTI
February 6, 2021
However, the Chinese company producing the vaccine is yet to submit all necessary documents to the Nepal government. Without the green signal from the government, the Sinopharm's vaccine cannot be brought to Nepal


BusinessToday.In
New Delhi, February 5, 2021
Pfizer Inc has withdrawn its application for emergency-use authorization of its COVID-19 vaccine in India that it had developed with Germany's BioNTech. The US company, which was the first drugmaker to apply for emergency use authorization of its coronavirus vaccine in India, had a meeting with the country's drugs regulator on Wednesday and the decision was made after that, the company said. India's Central Drugs Standard Control Organisation had declined to accept Pfizer's request for approval without a small local trial on the vaccine's safety and immunogenicity for Indians. Watch the video for more.Also Read: Pfizer withdraws emergency use application for COVID-19 vaccine in India


PAGES 4 OF 73  12345